Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer
R Charkiewicz, A Sulewska, R Mroz, A Charkiewicz… - Cancers, 2023 - mdpi.com
Simple Summary Non-small cell lung cancer (NSCLC) is a prevalent and lethal disease.
Circulating cell-free miRNA has the potential to serve as a biomarker for early detection as it …
Circulating cell-free miRNA has the potential to serve as a biomarker for early detection as it …
Investigation of key miRNAs and Target-mRNA in Kaposi's sarcoma using bioinformatic methods
T Wang, J Zheng, Y Pan, Z Zhuang, Y Zeng - Heliyon, 2024 - cell.com
Kaposi's sarcoma (KS) is the second most common tumor in human immunodeficiency virus
(HIV) infected patients worldwide. While many miRNAs have been confirmed to be involved …
(HIV) infected patients worldwide. While many miRNAs have been confirmed to be involved …